Merit Medical Systems Inc revenue by segment MMSI

Annual Quarterly

Merit Medical Systems Inc splits its revenue into 15 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Foundational Access at $157.9 million, 38% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024
Revenue	1,611	416	419	382	394	384	382	355	355
Foundational	—	—	281 share 67.1%	255 +6.3% share 66.9%	—	—	—	240 share 67.6%	—
Foundational Access	—	158 share 37.9%	—	—	—	—	—	—	—
Peripheral Intervention	—	—	—	—	155 +10.4% share 39.3%	—	—	—	140 share 39.5%
Therapeutic	—	141 share 33.8%	138 share 32.9%	126 +9.9% share 33.1%	—	—	—	115 share 32.4%	—
Cardiac Intervention	—	—	—	—	117 +22.5% share 29.8%	117 share 30.4%	—	—	96 share 26.9%
Custom Procedural Solutions	—	—	—	—	54 +4.7% share 13.6%	54 share 14.1%	—	—	51 share 14.4%
OEM	—	—	—	—	48 -4.7% share 12.2%	—	—	—	50 share 14.2%
Foundational Original Equipment Manufacturer	—	46 share 11.1%	—	—	—	—	43 share 11.3%	—	—
Foundational Vascular Intervention	—	—	—	—	—	—	35 share 9.1%	—	—
Therapeutic Vascular Intervention	—	—	34 share 8.2%	—	—	—	—	—	—
Foundational Procedural Solutions	—	27 -15.9% share 6.5%	28 -11.9% share 6.7%	—	—	32 share 8.4%	32 share 8.3%	—	—
Therapeutic Endoscopy	—	23 share 5.6%	24 +28.5% share 5.6%	—	—	—	18 share 4.8%	—	—
Endoscopy Devices	—	—	—	—	20 +14.9% share 5.1%	18 share 4.6%	—	—	17 share 4.9%
Therapeutic Original Equipment Manufacturer	—	13 +31.5% share 3.1%	13 +31.5% share 3.1%	—	—	10 share 2.6%	10 share 2.5%	—	—
Product And Service Other	—	2 +807.7% share 0.5%	1 +257.2% share 0.3%	—	—	0 share 0.1%	0 share 0.1%	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: MMSI (Nasdaq)
Fiscal year ends: December 31
Incorporated in: UT
Headquarters: South Jordan, UT
SEC filer status: Large accelerated filer
SEC CIK: 856982

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.